Stephen Vanni has been appointed general manager of Catalent Pharma Solutions’ Braeside facility in Melbourne, Australia.
 
The 331,055 sq.-ft. facility is one of the company’s strategic hubs within the Asia Pacific region and has both softgel and solid dose manufacturing operations.
 
Mr. Vanni joins the company from Aspen Pharma, where he was Southern Region Plant Manager, based at the company’s Dandenong facility, responsible for plant safety, quality and regulatory compliance, as well financial oversight. Mr. Vanni has more than 20 years of experience in the chemical and food production industries, and has previously worked for ICI Australia, and Bristol-Myers Squibb.
 
“Stephen will play a central role in the strategic growth of Catalent’s business within Australia and the greater Asia-Pacific region,” said Mark Bisset, president of Catalent Asia Pacific.“His insight and experience will be invaluable to our growing Executive Leadership team as we look to continue to expand our reach within the consumer health and over the counter formulations space in this marketplace.”

Visit Catalent at Tables 71, 72